SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Doc Bones12/7/2005 4:35:22 AM
   of 416
 
Flu Vaccine Causes Only a Few Reports Of Adverse Effects

ASSOCIATED PRESS
December 7, 2005; Page D7

Few serious side effects have been reported since the inhaled flu vaccine FluMist became available nationwide two years ago.

About 2.5 million people in the U.S. have received FluMist, manufactured by MedIummune Inc., which is intended for healthy people ages 5 to 49.

Of 460 "adverse events" possibly linked to the vaccine and voluntarily reported to the U.S. Vaccine Adverse Event Reporting System through August, 40 were considered serious, including breathing problems in asthma patients and life-threatening allergic reactions.

The figures echo previous reports about FluMist's safety and show that the vaccine is safe when used as directed, government researchers said.

The study appears in today's Journal of the American Medical Association. It was conducted by researchers from the Food and Drug Administration and the Centers for Disease Control and Prevention. The agencies operate the VAERS system.

Unlike flu shots, FluMist contains live but weakened influenza virus -- the reason it isn't recommended for people at highest risk for flu complications, such as the elderly, children and people with asthma or other chronic diseases.

Overall, there were 73 reports of possible side effects in patients who shouldn't have been given FluMist. Eight of the 12 reported asthma cases happened in patients with a history of asthma.

Past shortages of injectable flu vaccine might have led some doctors to give FluMist to asthmatics and other patients for whom it isn't approved, said Gary Noskin, chief of epidemiology at Northwestern Memorial Hospital in Chicago. Some may have thought the risks associated with the flu outweighed the risks from the vaccine, Dr. Noskin said.

The number of cases of improper use "is really a small subset -- it shows that the system is working," said the study's lead author, Hector Izurieta of the FDA. "I don't think it suggests people are using it in an arbitrary way."

No vaccine shortages are expected this flu season.

FluMist was introduced in 2003.

online.wsj.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext